Hide metadata

dc.date.accessioned2020-05-13T17:56:34Z
dc.date.available2020-05-13T17:56:34Z
dc.date.created2019-04-18T22:44:07Z
dc.date.issued2019
dc.identifier.citationItkonen, Harri Urbanucci, Alfonso Sara ES, Martin Khan, Aziz Mathelier, Anthony Thiede, Bernd Walker, Suzanne Mills, Ian Geoffrey . High OGT activity is essential for MYC-driven proliferation of prostate cancer cells. Theranostics. 2019, 9(8), 2183-2197
dc.identifier.urihttp://hdl.handle.net/10852/75526
dc.description.abstractO-GlcNAc transferase (OGT) is overexpressed in aggressive prostate cancer. OGT modifies intra-cellular proteins via single sugar conjugation (O-GlcNAcylation) to alter their activity. We recently discovered the first fast-acting OGT inhibitor OSMI-2. Here, we probe the stability and function of the chromatin O-GlcNAc and identify transcription factors that coordinate with OGT to promote proliferation of prostate cancer cells. Methods: Chromatin immunoprecipitation (ChIP) coupled to sequencing (seq), formaldehyde-assisted isolation of regulatory elements, RNA-seq and reverse-phase protein arrays (RPPA) were used to study the importance of OGT for chromatin structure and transcription. Mass spectrometry, western blot, RT-qPCR, cell cycle analysis and viability assays were used to establish the role of OGT for MYC-related processes. Prostate cancer patient data profiled for both mRNA and protein levels were used to validate findings. Results: We show for the first time that OGT inhibition leads to a rapid loss of O-GlcNAc chromatin mark. O-GlcNAc ChIP-seq regions overlap with super-enhancers (SE) and MYC binding sites. OGT inhibition leads to down-regulation of SE-dependent genes. We establish the first O-GlcNAc chromatin consensus motif, which we use as a bait for mass spectrometry. By combining the proteomic data from oligonucleotide enrichment with O-GlcNAc and MYC ChIP-mass spectrometry, we identify host cell factor 1 (HCF-1) as an interaction partner of MYC. Inhibition of OGT disrupts this interaction and compromises MYC's ability to confer androgen-independent proliferation to prostate cancer cells. We show that OGT is required for MYC-mediated stabilization of mitotic proteins, including Cyclin B1, and/or the increased translation of their coding transcripts. This implies that increased expression of mRNA is not always required to achieve increased protein expression and confer aggressive phenotype. Indeed, high expression of Cyclin B1 protein has strong predictive value in prostate cancer patients (p=0.000014) while mRNA does not. Conclusions: OGT promotes SE-dependent gene expression. OGT activity is required for the interaction between MYC and HCF-1 and expression of MYC-regulated mitotic proteins. These features render OGT essential for the androgen-independent, MYC-driven proliferation of prostate cancer cells. Androgen-independency is the major mechanism of prostate cancer progression, and our study identifies OGT as an essential mediator in this process.en_US
dc.languageEN
dc.publisherIvyspring International Publisher
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleHigh OGT activity is essential for MYC-driven proliferation of prostate cancer cellsen_US
dc.typeJournal articleen_US
dc.creator.authorItkonen, Harri
dc.creator.authorUrbanucci, Alfonso
dc.creator.authorSara ES, Martin
dc.creator.authorKhan, Aziz
dc.creator.authorMathelier, Anthony
dc.creator.authorThiede, Bernd
dc.creator.authorWalker, Suzanne
dc.creator.authorMills, Ian Geoffrey
cristin.unitcode185,57,0,0
cristin.unitnameNorsk Senter for Molekylærmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1693174
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Theranostics&rft.volume=9&rft.spage=2183&rft.date=2019
dc.identifier.jtitleTheranostics
dc.identifier.volume9
dc.identifier.issue8
dc.identifier.startpage2183
dc.identifier.endpage2197
dc.identifier.doihttps://doi.org/10.7150/thno.30834
dc.identifier.urnURN:NBN:no-78655
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1838-7640
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/75526/2/v09p2183.pdf
dc.type.versionPublishedVersion
dc.relation.projectNFR/144182
dc.relation.projectNFR/187615


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International